Substance abuse

R-466 Revocations Related to Substance Use among Federally Sentenced Men with Substance Use Needs: Comparing Correctional Program Participants and Eligible non-Participants (2023)

R-450 Examining Experiences of Federal Offenders on Opioid Agonist Treatment (OAT) During Release from Incarceration in Ontario, Canada: A Post-Release Report (2023)

R-449 Examining Experiences of Federal Offenders on Opioid Agonist Treatment (OAT) During Incarceration in Ontario, Canada: A Pre-Release Report (2023)

R-447 Optimization of Fetal Alcohol Spectrum Disorder Screening in Correctional Settings via Harmonization of Archival Datasets (2023)

R-436 Characteristics, Institutional Behaviour, and Post-release Success of Opioid Agonist Treatment (OAT) Participants: Examining Differences across OAT Options (Farrell MacDonald, S. & Beauchamp, T., 2022)

R-421 Application of Technological Advances in the Assessment and Treatment of Addiction in Corrections (Amlung, Vedelago, Morris, Petker, Balodis, McLachlan, Mamak, Moulden, Chaimowitz, and MacKillop, 2018)

R-398 Health and service access challenges for correctional offenders with mental health and substance use problems in transition from incarceration to community: A literature review (Murphy, Ali, and Fischer, 2018)

R-379 Comorbid Mental Disorders: Prevalence and Impact on Institutional Outcomes (Stewart, and Wilton, 2017)

R-358 Women Offenders, Substance Use, and Behaviour (Farrell-MacDonald, Gobeil, Biro, Ritchie, and Curno, 2015)

R-346 Assessing Fetal Alcohol Spectrum Disorder in Women Offenders (Forrester, Davis, Moser, MacPherson, Gobeil and Chudley, 2015)

R-340 Promising Intervention Approaches for Offenders with Cognitive Deficits Related to Fetal Alcohol Spectrum Disorder (FASD) and Other Neuropsychological Disorders (Forrester, Nolan, Stewart, Mullins and MacPherson, 2015)

R-335 Outcomes for Sex Offenders with Concurrent Substance Abuse and Mental Health Disorders (Wilton, Stewart and Mossière, 2014)

R-326 Distinguishing Characteristics of Substance Abuse Program Completers and Non-Completers (Richer, Lemelin and Ternes, 2014)

R-323 Institutional Adjustment of Methadone Maintenance Treatment Program Participants (Cheverie, MacSwain, Farrell-MacDonald and Johnson, 2014)

R-322 Post-Release Outcomes of Methadone Maintenance Treatment Program (MMTP) Participants: A Comparative Study (MacSwain, Farrell-MacDonald and Cheverie, 2014)

R-307 Characteristics of Women Participants in the Methadone Maintenance Treatment Program (MMTP) (MacSwain, Cheverie, Farrell-MacDonald and Johnson, 2014)

R-299 Characteristics, Institutional Adjustment, and Post-Release Success of Drug and Alcohol Users (Cheverie, Ternes and Farrell-MacDonald, 2014)

R-291 An Examination of the Effectiveness of the National Substance Abuse Program Moderate Intensity (NSAP-M) on Institutional Adjustment and Post-Release Outcomes (Ternes, Doherty and Matheson, 2014)

R-290 An Examination of the Effectiveness of the National Substance Abuse Program - High Intensity (NSAP-H) on Institutional Adjustment and Post-Release Outcomes (Doherty, Ternes and Matheson, 2014)

R-284 Institutional Adjustment of Offenders Living with Fetal Alcohol Spectrum Disorder (FASD) in a Canadian Federal Penitentiary (Mullins, MacPherson, Moser and Matheson, 2014)

R-277 Outcomes for Offenders with Concurrent Substance Abuse and Mental Health Disorders (Wilton and Stewart, 2012)

R-253 Characteristics of Participants in the Methadone Maintenance Treatment (MMT) Program (Johnson, Farrell-MacDonald and Cheverie, 2011)

R-247 Fetal Alcohol Spectrum Disorder (FASD) in a correctional population: Prevalence, screening and characteristics (MacPherson, Chudley and Grant, 2011)

R-232 Assessing the Impact of Enhanced Drug Interdiction Activities at Kingston Penitentiary: A Pilot Study (Johnson, Cheverie and Moser, 2010)

R-217 The Aboriginal Offender Substance Abuse Program (AOSAP): Examining the effects of successful completion on post-release outcomes (Kunic and Varis, 2010)

B-48 Buprenorphine Maintenance Treatment for Opioid Dependent Inmates (Cheverie, Johnson and Moser, 2010) See Brief (B) disclaimer

ERR-19-15 Measures of Impulsivity and Decision-Making: Emerging Research Results (2019)

ERR-12-04 Institutional Adjustment of Methadone Maintenance Treatment Program (MMTP) Participants: A Comparative Study (2012)

ERR-12-03 Post Release Outcomes of Methadone Maintenance Treatment Program (MMTP) Participants: A Comparative Study (2012)

ERR-12-02 Characteristics of Women Participants in the Methadone Maintenance Treatment Program (MMTP) (2012)

RIB-23-21 Non-Fatal Overdose Incidents in Federal Custody, 2020-2021 (2023)

RIB-23-20 Indigenous and non-Indigenous Women Offenders' Substance Use over Time: 2010 to 2021 (2023)

RIB-23-19 Women Offenders' Substance Use over Time: 2010 to 2021 (2023)

RIB-23-18 Substance Use Patterns of Women Offenders across Ethnocultural Groups (2023)

RIB-23-17 Women Offenders' Substance Use Patterns across Regions (2023)

RIB-23-16 Men Offenders with a History of Substance Use During a Prior Incarceration (2023)

RIB-23-01 Overdose Incidents in Federal Custody, 2019/2020 (2023)

RIB-22-04 Follow-up study of inmates under opioid agonist treatment before and after release (2023) new

RIB-20-08 Men Offenders’ Substance Use Patterns: An Ethnocultural Comparison over Time (2006 to 2019) (2022)

RIB-20-07 Regional Examination of Federal Men Offender's Substance Use Patterns: 2006 to 2019 (2022)

RIB-20-06 Federal Men Offenders' Substance Use Patterns over Time: 2006 to 2019 (2022)

RIB-19-09 Comparison of Women Offenders Who Use Opioids versus Other Types of Substances (2019)

RIB-19-08 Substance Use Patterns of Indigenous and Non-Indigenous Women Offenders (2019)

RIB-15-07 Comparison of Characteristics Across Types of Substance Users (2015)

RIB-15-03 Drug Overdose Among Federally Incarcerated Men Offenders (2015)

RIB-15-01 Substance Use and Behaviour: The Role of Gender (2015)

RIB-14-45 Regional Comparisons of Men and Women Offenders-Substance Use (2015)

RIB-14-44 Comparing Lifetime Substance Use Patterns of Men and Women Offenders (2015)

RIB-14-43 Lifetime Substance Use Patterns of Men Offenders (2015)

RIB-23-39 Non-Fatal Overdose Incidents in Federal Custody, 2021/2022 (2023) new

RR-12-01 Drug-related Deaths among Recently Released Offenders: A Review of the Literature (2012)

RR-10-01 Traumatic Brain Injury and Substance Use Among Offenders (2010)

RS-14-28 Substance Use During Pregnancy Among Women Offenders (2014)

RS-14-26 Comparing Substance Use Patterns of Aboriginal and Non-Aboriginal Women Offenders (2014)

RS-14-24 Lifetime Substance Use Patterns of Women Offenders (2014)

RS-14-19 Severity of Substance Use, Discretionary Release, and Return to Federal Custody (2014)

RS-14-05 Urinalysis Results from the 2012/13 Fiscal Year (2014)

RS-13-09 Concurrent Disorders and Substance Abuse Disorders Among Ethnic Offenders (2014)

RS-13-05 Substance Abuse Problem Severity, Treatment Readiness and Response Bias among Incarcerated Male Offenders (2014)

RS-13-03 Aboriginal Offender Substance Abuse Program (AOSAP) and Cultural Engagement (2013)

RS-13-02 The Cultural, Social and Substance Use Histories of Male Offenders Enrolled in the Aboriginal Offender Substance Abuse Program (AOSAP) (2013)

RS-13-01 Substance Use on Day Offence in a Sample of Male Federal Offenders (2013)

RS-12-10 Offender Substance Use Patterns: Aboriginal and Non-Aboriginal Offenders (2012)

RS-12-09 Comparing the Mental Health Treatment and Abuse Histories of Men and Women Methadone Maintenance Treatment Program (MMTP) Participants (2012)

RS-12-08 Comparing the Mental Health Treatment and Abuse Histories of Aboriginal and Non-Aboriginal Participants of the Methadone Maintenance Treatment Program (MMTP) (2012)

RS-11-06 Linking Type of Substance Use and Type of Crime in Male Offenders (2011)

RS-11-05 The Validity of Self-Reported Drug Use with Male Offenders (2011)

RS-11-03 Offender Satisfaction with the Computerized Assessment of Substance Abuse (CASA) (2011)

RS-10-02 Prevalence of Injection Drug Use among Male Offenders (2010)